Baillie Gifford & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $343M | Sell |
698,441
-72,427
| -9% | -$39.3M | 0.35% | 60 |
|
|
2025
Q4 | $447M | Buy |
770,868
+279,635
| +57% | +$158M | 0.37% | 52 |
|
|
2025
Q3 | $238M | Sell |
491,233
-13,443
| -3% | -$6.26M | 0.18% | 90 |
|
|
2025
Q2 | $205M | Sell |
504,676
-4,701
| -0.9% | -$1.97M | 0.15% | 97 |
|
|
2025
Q1 | $253M | Sell |
509,377
-29,480
| -5% | -$16M | 0.22% | 76 |
|
|
2024
Q4 | $280M | Sell |
538,857
-64,537
| -11% | -$35.5M | 0.22% | 76 |
|
|
2024
Q3 | $373M | Sell |
603,394
-18,122
| -3% | -$10.7M | 0.28% | 70 |
|
|
2024
Q2 | $344M | Sell |
621,516
-9,733
| -2% | -$5.58M | 0.27% | 72 |
|
|
2024
Q1 | $367M | Sell |
631,249
-39,916
| -6% | -$22.4M | 0.29% | 69 |
|
|
2023
Q4 | $356M | Sell |
671,165
-25,769
| -4% | -$12.5M | 0.28% | 76 |
|
|
2023
Q3 | $353M | Sell |
696,934
-16,513
| -2% | -$8.8M | 0.32% | 69 |
|
|
2023
Q2 | $372M | Sell |
713,447
-480,342
| -40% | -$259M | 0.32% | 73 |
|
|
2023
Q1 | $688M | Sell |
1,193,789
-83,105
| -7% | -$46.8M | 0.62% | 39 |
|
|
2022
Q4 | $703M | Sell |
1,276,894
-60,833
| -5% | -$32.2M | 0.73% | 34 |
|
|
2022
Q3 | $678M | Sell |
1,337,727
-28,448
| -2% | -$15.9M | 0.7% | 39 |
|
|
2022
Q2 | $742M | Sell |
1,366,175
-13,145
| -1% | -$7.24M | 0.76% | 37 |
|
|
2022
Q1 | $815M | Sell |
1,379,320
-111,772
| -7% | -$64.2M | 0.57% | 47 |
|
|
2021
Q4 | $995M | Sell |
1,491,092
-6,174
| -0.4% | -$3.85M | 0.55% | 53 |
|
|
2021
Q3 | $855M | Sell |
1,497,266
-7,024
| -0.5% | -$3.86M | 0.45% | 58 |
|
|
2021
Q2 | $759M | Buy |
1,504,290
+49,908
| +3% | +$23.5M | 0.37% | 72 |
|
|
2021
Q1 | $664M | Sell |
1,454,382
-727,201
| -33% | -$347M | 0.37% | 69 |
|
|
2020
Q4 | $1.02B | Sell |
2,181,583
-56,300
| -3% | -$26.4M | 0.57% | 42 |
|
|
2020
Q3 | $988M | Sell |
2,237,883
-28,053
| -1% | -$11.6M | 0.68% | 36 |
|
|
2020
Q2 | $821M | Buy |
2,265,936
+61,814
| +3% | +$20.7M | 0.63% | 37 |
|
|
2020
Q1 | $625M | Sell |
2,204,122
-17,634
| -0.8% | -$5.56M | 0.68% | 32 |
|
|
2019
Q4 | $722M | Sell |
2,221,756
-75,687
| -3% | -$22.9M | 0.7% | 30 |
|
|
2019
Q3 | $669M | Sell |
2,297,443
-57,736
| -2% | -$16.5M | 0.76% | 29 |
|
|
2019
Q2 | $692M | Sell |
2,355,179
-3,215
| -0.1% | -$885K | 0.73% | 29 |
|
|
2019
Q1 | $646M | Sell |
2,358,394
-11,500
| -0.5% | -$2.86M | 0.71% | 33 |
|
|
2018
Q4 | $530M | Sell |
2,369,894
-11,231
| -0.5% | -$2.64M | 0.69% | 34 |
|
|
2018
Q3 | $581M | Buy |
2,381,125
+2,935
| +0.1% | +$675K | 0.63% | 38 |
|
|
2018
Q2 | $493M | Sell |
2,378,190
-24,757
| -1% | -$5.26M | 0.53% | 43 |
|
|
2018
Q1 | $496M | Sell |
2,402,947
-20,071
| -0.8% | -$4.21M | 0.58% | 38 |
|
|
2017
Q4 | $460M | Buy |
+2,423,018
| New | +$464M | 0.57% | 40 |
|
Other funds holding TMO
VCM
Baillie Gifford & Co's TMO Position: Q1 2026 in Review
Baillie Gifford & Co reduced its Thermo Fisher Scientific (TMO) stake by 9.4% in Q1 2026, selling an estimated $39.3M and leaving 698,441 shares worth $343M. The position accounts for 0.35% of the portfolio, ranked #60.
Baillie Gifford & Co first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.02B in Q4 2020. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Baillie Gifford & Co held 698,441 shares of Thermo Fisher Scientific worth $343M as of Q1 2026.
- Baillie Gifford & Co sold 72,427 Thermo Fisher Scientific shares in Q1 2026, an estimated $39.3M.
- Thermo Fisher Scientific made up 0.35% of Baillie Gifford & Co's portfolio in Q1 2026, its #60 holding.
- Baillie Gifford & Co first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
- Baillie Gifford & Co's Thermo Fisher Scientific position peaked at $1.02B in Q4 2020.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Baillie Gifford & Co's 13F filing for Q1 2026, filed 8 May 2026.